You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nephritis, Hereditary

Showing 1 - 25 of 1,031
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

Recruiting
  • Alport Syndrome
    • Paris, Île-de-France, France
      RaDiCo Eurbio-Alport
    Jun 22, 2023

    Alport Syndrome, Metformin Trial (Metformin, Placebo)

    Not yet recruiting
    • Alport Syndrome
    • Metformin
    • (no location specified)
    Dec 16, 2022

    Alport Syndrome Trial in Minneapolis

    Recruiting
    • Alport Syndrome
      • Minneapolis, Minnesota
        University of Minnesota
      Mar 25, 2022

      Biomarker for Alport Syndrome (BioAlport)

      Active, not recruiting
      • Nephritis, Hereditary
      • Hematuria-Nephropathy-Deafness Syndrome
        • Tirana, Albania
        • +6 more
        Mar 23, 2022

        Chronic Kidney Disease, Dialysis, Kidney Transplant Trial in Danville (Observational study - registry)

        Recruiting
        • Chronic Kidney Disease
        • +3 more
        • Observational study - registry
        • Danville, Pennsylvania
          Geisinger Clinic
        Aug 9, 2022

        Alport Syndrome Trial in Clayton, Parkville, London (ELX-02)

        Recruiting
        • Alport Syndrome
        • Clayton, Victoria, Australia
        • +3 more
        Dec 19, 2022

        Alport Syndrome Trial in Shanghai (Ramipril)

        Not yet recruiting
        • Alport Syndrome
        • Shanghai, China
          Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
        Nov 23, 2021

        Alport Syndrome, X-Linked Trial in Shanghai (Hydroxychloroquine Sulfate 100 milligram (mg) Tab, Benazepril HCl 10 milligram (mg)

        Recruiting
        • Alport Syndrome, X-Linked
        • Hydroxychloroquine Sulfate 100 milligram (mg) Tab
        • Benazepril hydrochloride 10 milligram (mg) Tab
        • Shanghai, Shanghai, China
          Shanghai Children's Hospital
        Sep 8, 2021

        Alport Syndrome Trial in United States (RG012)

        Completed
        • Alport Syndrome
        • La Mesa, California
        • +6 more
        Apr 21, 2022

        Genotype-Phenotype Correlations in Patients With Alport Syndrome

        Recruiting
        • Alport Syndrome
          • Shanghai, China
            China Xinhua Hospital, Shanghai Jiao Tong University School of M
          Jun 24, 2021

          Alport Syndrome, Focal Segmental Glomerulosclerosis Trial in United States (R3R01)

          Recruiting
          • Alport Syndrome
          • Focal Segmental Glomerulosclerosis
          • Los Angeles, California
          • +10 more
          Aug 15, 2022

          Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

          Recruiting
          • Adenine Phosphoribosyltransferase Deficiency
          • +83 more
            • Bristol, South West, United Kingdom
              Zoe Plummer
            Sep 26, 2023

            Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

            Recruiting
            • Focal Segmental Glomerulosclerosis
            • +4 more
            • Wilmington, Delaware
            • +32 more
            Jan 10, 2023

            Baby Detect : Genomic Newborn Screening

            Recruiting
            • Congenital Adrenal Hyperplasia
            • +126 more
              • Liege, Wallonia, Belgium
                CRMN, Hôpital La Citadelle
              Jan 24, 2023

              IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome Trial in Worldwide (Atrasentan)

              Recruiting
              • IgA Nephropathy
              • +5 more
              • Huntsville, Alabama
              • +37 more
              Dec 1, 2022

              Renal Insufficiency, Chronic Trial in Goettingen (Ramipril, to ramipril)

              Completed
              • Renal Insufficiency, Chronic
              • Goettingen, Germany
                University Medical Center Goettingen
              Jun 15, 2020

              Alport Syndrome Trial in Worldwide (Placebo Oral Capsule, Bardoxolone Methyl)

              Completed
              • Alport Syndrome
              • Placebo Oral Capsule
              • Bardoxolone Methyl
              • Birmingham, Alabama
              • +62 more
              Mar 22, 2022

              Disease Study in Alport Syndrome Patients

              Completed
              • Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
                • San Diego, California
                • +14 more
                Jun 28, 2019

                Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

                Recruiting
                • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
                • ANCA-Associated Glomerulonephritis
                • Chongqing, Chongqing, China
                  Children's Hospital of Chongqing Medical University
                Jul 23, 2023

                Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

                Recruiting
                • Lupus Nephritis
                • +2 more
                • Methylprednisolone Injectable Suspension
                • +2 more
                • Nanjing, Jiangsu, China
                  Jiong Zhang
                May 8, 2023

                Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

                Recruiting
                • Lupus Nephritis
                • +2 more
                • KYV-101 anti-CD19 CAR-T cell therapy
                • Standard lymphodepletion regimen
                • Denver, Colorado
                • +1 more
                Jul 7, 2023

                AntiDFS70 Lupus Nephritis

                Recruiting
                • Systemic Lupus Erythematosus
                • anti dfs70 antibodies
                • Sohag, Egypt
                  Sohag university Hospital
                Nov 6, 2023

                Lupus Nephritis Trial in China (efgartigimod IV, Placebo)

                Recruiting
                • Lupus Nephritis
                • efgartigimod IV
                • Placebo
                • Beijing, China
                • +9 more
                Apr 11, 2023

                Lupus Nephritis Trial (Felzartamab)

                Not yet recruiting
                • Lupus Nephritis
                • (no location specified)
                Sep 26, 2023

                Lupus Nephritis Trial in Philippines, Taiwan (ANX009)

                Recruiting
                • Lupus Nephritis
                • ANX009
                • Angeles City, Philippines
                • +6 more
                Mar 10, 2023